VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q5494705 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000035.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q5494705‏
035 ‎‡a (OCoLC)Q5494705‏
043 ‎‡c GB‏
046 ‎‡f 19250131‏ ‎‡g 20040220‏
100 0 ‎‡a Fred Brown‏ ‎‡c British virologist (1925-2004)‏ ‎‡9 en‏
370 ‎‡c United Kingdom of Great Britain and Ireland‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Fred Brown‏ ‎‡c ahli biologi asal Britania Raya‏ ‎‡9 id‏
400 0 ‎‡a Fred Brown‏ ‎‡c biólogo británico‏ ‎‡9 es‏
400 0 ‎‡a Фред Браун‏ ‎‡9 ru‏
400 0 ‎‡a Fred Brown‏ ‎‡c Brits bioloog (1925-2004)‏ ‎‡9 nl‏
400 0 ‎‡a Fred Brown‏ ‎‡c biologiste, en poste: Plum Island disease center, Greenport, N. Y.‏ ‎‡9 fr‏
400 0 ‎‡a ফ্রেড ব্রাউন‏ ‎‡9 bn‏
400 0 ‎‡a フレッド・ブラウン‏ ‎‡c イギリスのウイルス học giả (1925-2004)‏ ‎‡9 ja‏
670 ‎‡a Author's 3′-Terminal nucleotide sequences in the genome RNA of picornaviruses‏
670 ‎‡a Author's A CD strategy for the study of polypeptide folding/unfolding. A synthetic foot-and-mouth disease virus immunogenic peptide‏
670 ‎‡a Author's A Comparative Chemical and Serological Study of the Full and Empty Particles of Foot-and Mouth Disease Virus‏
670 ‎‡a Author's A Comparative Study of the Surface Projections of Different Strains of Vesicular Stomatitis Virus‏
670 ‎‡a Author's A foot and mouth disease syndrome in pigs caused by an enterovirus‏
670 ‎‡a Author's A High Density Component in Several Vertebrate Enteroviruses‏
670 ‎‡a Author's A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles‏
670 ‎‡a Author's A model for foot-and-mouth disease virus‏
670 ‎‡a Author's A Model for Vesicular Exanthema Virus, the Prototype of the Calicivirus Group‏
670 ‎‡a Author's A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses‏
670 ‎‡a Author's A physico-chemical sub-grouping of the mammalian picornaviruses‏
670 ‎‡a Author's A Re-appraisal of the Biochemical Map of Foot-and-mouth Disease Virus RNA‏
670 ‎‡a Author's A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies.‏
670 ‎‡a Author's A study of the heterogeneous 37S ribonucleic acid induced by foot-and-mouth-disease virus‏
670 ‎‡a Author's A Study of the Level of Nucleotide Sequence Conservation between the RNAs of Two Serotypes of Foot-and-Mouth Disease Virus‏
670 ‎‡a Author's A study of the level of nucleotide sequence conservation between the RNAs of two types serotypes of foot-and-mouth disease virus.‏
670 ‎‡a Author's A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge‏
670 ‎‡a Author's A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2‏
670 ‎‡a Author's A universal virus inactivant for decontaminating blood and biopharmaceutical products‏
670 ‎‡a Author's Absence of poly‏
670 ‎‡a Author's Absence of Poly (A) from the Infective RNA of Nodamura Virus‏
670 ‎‡a Author's Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals‏
670 ‎‡a Author's An Assessment by Competition Hybridization of the Sequence Homology between the RNAs of the Seven Serotypes of FMDV‏
670 ‎‡a Author's An Inactivated Baby Hamster Kidney Cell Rabies Vaccine for Use in Dogs and Cattle‏
670 ‎‡a Author's An interfering component of rabies virus which contains RNA.‏
670 ‎‡a Author's Analysis of the secondary structure of the poly‏
670 ‎‡a Author's Analysis of the secondary structure of the poly(C) tract in foot-and-mouth disease virus RNAs‏
670 ‎‡a Author's Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor‏
670 ‎‡a Author's Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production‏
670 ‎‡a Author's Application of RNase T1 one- and two-dimensional analyses to the rapid identification of foot-and-mouth disease viruses‏
670 ‎‡a Author's Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination.‏
670 ‎‡a Author's Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals‏
670 ‎‡a Author's Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals‏
670 ‎‡a Author's Biochemical Analysis of a Virulent and an Avirulent Strain of Foot-and-Mouth Disease Virus‏
670 ‎‡a Author's Biochemical Aspects of Variation in Foot-and-Mouth Disease Virus‏
670 ‎‡a Author's Biochemical Mapping of the Foot-and-Mouth Disease Virus Genome‏
670 ‎‡a Author's Buoyant density of picornaviruses in caesium salts‏
670 ‎‡a Author's Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations‏
670 ‎‡a Author's Characterisation of a rotavirus‏
670 ‎‡a Author's Characterisation of a rotavirus.20b.‏
670 ‎‡a Author's Characterization of an acid-resistant mutant of foot-and-mouth disease virus‏
670 ‎‡a Author's Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides‏
670 ‎‡a Author's Characterization of the Minor Polypeptides in the Foot-and-Mouth Disease Particle‏
670 ‎‡a Author's Chemical basis of antigenic variation in foot-and-mouth disease virus‏
670 ‎‡a Author's Chemically Synthesized Peptides Elicit Neutralizing Antibody to Bovine Enterovirus‏
670 ‎‡a Author's Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation‏
670 ‎‡a Author's Classification of rhabdovirus proteins: a proposal.‏
670 ‎‡a Author's Comparative Biochemical and Serological Analysis of Five Isolates of a Single Serotype of Foot-and-Mouth Disease Virus‏
670 ‎‡a Author's Comparison of Bluetongue Type 20 with Certain Viruses of the Bluetongue and Eubenangee Serological Groups of Orbiviruses‏
670 ‎‡a Author's Comparison of Swine Vesicular Disease Virus and Coxsackie B5 Virus by Serological and RNA Hybridization Methods‏
670 ‎‡a Author's Comparison of the Antibodies Elicited by the Individual Structural Polypeptides of Foot-and-Mouth Disease and Polio Viruses‏
670 ‎‡a Author's Control of foot-and-mouth disease by vaccination‏
670 ‎‡a Author's Correlations between the conformations elucidated by CD spectroscopy and the antigenic properties of four peptides of the foot-and-mouth disease virus‏
670 ‎‡a Author's Crystallization and preliminary X-ray diffraction analysis of foot-and-mouth disease virus.‏
670 ‎‡a Author's Delineation of a neutralizing subregion within the immunodominant epitope‏
670 ‎‡a Author's Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.‏
670 ‎‡a Author's Demonstration of three specific sites on the surface of foot-and-mouth disease virus by antibody complexing‏
670 ‎‡a Author's Differential precipitation of foot and mouth disease virus proteins made in vivo and in vitro by hyperimmune and virus particle guinea pig antisera‏
670 ‎‡a Author's Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins‏
670 ‎‡a Author's Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components‏
670 ‎‡a Author's Early Events in the Interaction Between Foot-and-Mouth Disease Virus and Primary Pig Kidney Cells‏
670 ‎‡a Author's Effect of actinomycin D and guanidine on the formation of a ribonucleic acid polymerase induced by foot-and mouth-disease virus and on the replication of virus and viral ribonucleic acid‏
670 ‎‡a Author's Effect of virus infection on the stability and synthesis of actinomycin-resistant ribonucleic acid in baby-hamster kidney cells‏
670 ‎‡a Author's Effective synthetic peptide vaccine for foot-and-mouth disease in swine‏
670 ‎‡a Author's Efficacy of rabies vaccine prepared from virus grown in duck embryo‏
670 ‎‡a Author's Encephalomyocarditis virus antibodies in sera from apparently normal pigs‏
670 ‎‡a Author's Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus‏
670 ‎‡a Author's Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies‏
670 ‎‡a Author's Evidence for a group protein in foot-and-mouth disease virus particles‏
670 ‎‡a Author's Evidence for an internal antigen in foot-and-mouth disease virus‏
670 ‎‡a Author's Evidence for the persistence of foot-and-mouth disease virus in pigs‏
670 ‎‡a Author's Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties‏
670 ‎‡a Author's Foot-and-mouth disease virus and poliovirus particles contain proteins of the replication complex‏
670 ‎‡a Author's Foot-and-mouth disease virus particles contain replicase protein 3D.‏
670 ‎‡a Author's Further evidence for multiple proteins in the foot-and-mouth disease virus particle‏
670 ‎‡a Author's Further Physicochemical Characterization of Nodamura Virus. Evidence that the Divided Genome Occurs in a Single Component‏
670 ‎‡a Author's Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals‏
670 ‎‡a Author's Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice‏
670 ‎‡a Author's Glycolipid nature of the complement-fixing host cell antigen of vesicular stomatitis virus‏
670 ‎‡a Author's Heterogeneity of the genome-linked protein of foot-and-mouth disease virus‏
670 ‎‡a Author's Host cell selection of antigenic variants of foot-and-mouth disease virus‏
670 ‎‡a Author's Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock‏
670 ‎‡a Author's Immune response to uncoupled peptides of foot-and-mouth disease virus‏
670 ‎‡a Author's Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses‏
670 ‎‡a Author's Immunogenic and Cell Attachment Sites of FMDV: Further Evidence for their Location in a Single Capsid Polypeptide‏
670 ‎‡a Author's Immunological evaluation of the multiple antigen peptide‏
670 ‎‡a Author's Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus‏
670 ‎‡a Author's Immunological priming with synthetic peptides of foot-and-mouth disease virus‏
670 ‎‡a Author's Immunological properties of hepatitis B core antigen fusion proteins‏
670 ‎‡a Author's Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein‏
670 ‎‡a Author's Inactivation of viruses by aziridines‏
670 ‎‡a Author's Induced ribonucleic acids in cells infected with vesicular stomatitis virus‏
670 ‎‡a Author's Infection of man by swine vesicular disease virus‏
670 ‎‡a Author's Infective virus substructure from vesicular stomatitis virus‏
670 ‎‡a Author's Interfering component of vesicular stomatitis virus‏
670 ‎‡a Author's Isolation of a soluble and template-dependent foot-and-mouth disease virus RNA polymerase‏
670 ‎‡a Author's Lipid and protein organization in vesicular stomatitis and Sindbis viruses‏
670 ‎‡a Author's Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA‏
670 ‎‡a Author's Mimicry of viral epitopes with retro-inverso peptides of increased stability.‏
670 ‎‡a Author's Model for vesicular stomatitis virus‏
670 ‎‡a Author's Molecular Aspects of the Antigenic Variation of Swine Vesicular Disease and Coxsackie B5 Viruses‏
670 ‎‡a Author's Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes‏
670 ‎‡a Author's Molecular weight of rhinovirus ribonucleic acid‏
670 ‎‡a Author's Moleculas aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses.‏
670 ‎‡a Author's More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA‏
670 ‎‡a Author's Myristylation of picornavirus capsid protein VP4 and its structural significance‏
670 ‎‡a Author's Nature of the Antibody Response to the Foot-and-Mouth Disease Virus Particle, its 12S Protein Subunit and the Isolated Immunizing Polypeptide VP1‏
670 ‎‡a Author's Nature of the inactivating action of trypsin on foot-and-mouth disease virus‏
670 ‎‡a Author's Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides‏
670 ‎‡a Author's Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites‏
670 ‎‡a Author's Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents‏
670 ‎‡a Author's New approaches to vaccination against foot-and-mouth disease‏
670 ‎‡a Author's Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants‏
670 ‎‡a Author's Physico-chemical characterisation of rinderpest virus‏
670 ‎‡a Author's Physico-chemical evidence for the re-classification of the caliciviruses‏
670 ‎‡a Author's Physicochemical Characterization of Two Serologically Unrelated Equine Rhinoviruses‏
670 ‎‡a Author's Presence of a Covalently Linked Protein on Calicivirus RNA‏
670 ‎‡a Author's Presentation and Immunogenicity of Viral Epitopes on the Surface of Hybrid Hepatitis B Virus Core Particles Produced in Bacteria‏
670 ‎‡a Author's Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.‏
670 ‎‡a Author's Proposal for a uniform nomenclature for defective interfering viruses of vesicular stomatitis virus‏
670 ‎‡a Author's Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence‏
670 ‎‡a Author's Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide.‏
670 ‎‡a Author's Protein covalently linked to foot-and-mouth disease virus RNA‏
670 ‎‡a Author's Proteins Induced by Infection with Caliciviruses‏
670 ‎‡a Author's Purification and Identification of the RNA-dependent RNA Polymerase of Foot-and-Mouth Disease Virus‏
670 ‎‡a Author's Purification and physicochemical characteristics of African swine fever virus‏
670 ‎‡a Author's Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides‏
670 ‎‡a Author's Questions concerning the potency of rabies vaccine‏
670 ‎‡a Author's Rabies vaccines for animals and man‏
670 ‎‡a Author's Rabies virus and laboratory regulations‏
670 ‎‡a Author's Rabies virus and the problems of rabies vaccination in man‏
670 ‎‡a Author's Reaction of glutaraldehyde with food-and-mouth disease virus‏
670 ‎‡a Author's Reactions between an insect picornavirus and naturally occurring IgM antibodies in several mammalian species‏
670 ‎‡a Author's Relationship of a virus from Tellina tenuis to infectious pancreatic necrosis virus‏
670 ‎‡a Author's Relationship of Encephalomyocarditis Virus to Cricket Paralysis Virus of Insects‏
670 ‎‡a Author's Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection‏
670 ‎‡a Author's Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate.‏
670 ‎‡a Author's Replication of foot-and-mouth disease virus ribonucleic acid‏
670 ‎‡a Author's Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses‏
670 ‎‡a Author's Ribonucleic acid synthesis in rinderpest virus infected cells‏
670 ‎‡a Author's Sequence and location of the poly C tract in aphtho- and cardiovirus RNA‏
670 ‎‡a Author's Sequence identification of antigenic variants in plaque isolates of foot-and-mouth disease virus‏
670 ‎‡a Author's Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.‏
670 ‎‡a Author's Serological and Immunological Relationships between the 146S and 12S Particles of Foot-and-Mouth Disease Virus‏
670 ‎‡a Author's Serological prospects for peptide vaccines against foot-and-mouth disease virus‏
670 ‎‡a Author's Serological relationships between different strains of vesicular stomatis virus‏
670 ‎‡a Author's Stabilising oral poliovaccine at high ambient temperatures‏
670 ‎‡a Author's Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus‏
670 ‎‡a Author's Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus‏
670 ‎‡a Author's Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines‏
670 ‎‡a Author's Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines‏
670 ‎‡a Author's Surface structure and RNA-protein interactions of foot-and-mouth disease virus‏
670 ‎‡a Author's Surface structure of foot-and-mouth disease virus‏
670 ‎‡a Author's Surface structure of vesicular stomatitis virus‏
670 ‎‡a Author's Synthesis of ribonucleic acid in baby-hamster kidney cells in the presence of actinomycin D.‏
670 ‎‡a Author's Synthetic peptide-based vaccine and diagnostic system for effective control of FMD‏
670 ‎‡a Author's Synthetic peptides as potential vaccines against foot-and-mouth disease‏
670 ‎‡a Author's Synthetic peptides mimic subtype specificity of foot-and-mouth disease virus‏
670 ‎‡a Author's The antigens of vesicular stomatitis virus. 3. Structure and immunogenicity of antigens derived from the virion by treatment with Tween and ether‏
670 ‎‡a Author's The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components‏
670 ‎‡a Author's The antigens of vesicular stomatitis virus. II. The presence of two low molecular weight immunogens in virus suspensions‏
670 ‎‡a Author's The assay, extraction and storage of infective ribonucleic acid from foot and mouth disease virus‏
670 ‎‡a Author's The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD‏
670 ‎‡a Author's The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).‏
670 ‎‡a Author's The eradication of foot-and-mouth disease: a parallel problem‏
670 ‎‡a Author's The history of research in foot-and-mouth disease‏
670 ‎‡a Author's The influence of mitomycin C, actinomycin D and ultraviolet light on the replication of the viruses of foot-and-mouth disease and vesicular stomatitis‏
670 ‎‡a Author's The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus.‏
670 ‎‡a Author's The Location of the Poly(C) Tract in the RNA of Foot-and-Mouth Disease Virus‏
670 ‎‡a Author's The morphologic characteristics of 19S antibody‏
670 ‎‡a Author's The potential of retro-inverso peptides as synthetic vaccines‏
670 ‎‡a Author's The proteins of biologically active sub-units of vesicular stomatitis virus‏
670 ‎‡a Author's The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus‏
670 ‎‡a Author's The solution conformational features of two highly homologous antigenic peptides of foot-and-mouth disease virus serotype A, variant A and USA, correlate with their serological properties‏
670 ‎‡a Author's The Solution Conformational Features of Two Highly Homologous Antigenic Peptides of Foot‐and‐mouth Disease Virus Serotype A, Variants A and USA, Correlate with their Serological Properties‏
670 ‎‡a Author's The Solution Structure of the Immunodominant and Cell Receptor Binding Regions of Foot‐and‐mouth Disease Virus Serotype A, Variant A‏
670 ‎‡a Author's The structure of foot-and-mouth disease virus: implications for its physical and biological properties.‏
670 ‎‡a Author's The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution‏
670 ‎‡a Author's Tryptic Peptide Analysis of the Structural Proteins of Vesicular Stomatitis Virus‏
670 ‎‡a Author's Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus‏
670 ‎‡a Author's Use of peptides for immunization against foot-and-mouth disease‏
670 ‎‡a Author's Variation in foot-and-mouth disease virus isolates in Kenya: an examination of field isolates by T1 oligonucleotide fingerprinting‏
670 ‎‡a Author's Virology‏
670 ‎‡a Author's West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation‏
670 ‎‡a Author's ウイルス học ‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/DNB|171991923‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/ISNI|0000000114475742‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/NTA|072009314‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/BNF|12280479‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/viaf/71452175‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/NKC|nlk20050163294‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/LC|n 84219996‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/SUDOC|031625770‏
670 ‎‡a wikidata authority control‏ ‎‡u https://viaf.org/processed/LNB|LNC10-000126490‏
670 ‎‡a wikidata site links‏ ‎‡u https://en.wikipedia.org/wiki/Fred_Brown_(virologist)‏
919 ‎‡a physicochemicalcharacterizationof2serologicallyunrelatedequinerhinoviruses‏ ‎‡A Physicochemical Characterization of Two Serologically Unrelated Equine Rhinoviruses‏ ‎‡9 1‏
919 ‎‡a physicochemicalevidenceforthereclassificationofthecaliciviruses‏ ‎‡A Physico-chemical evidence for the re-classification of the caliciviruses‏ ‎‡9 1‏
919 ‎‡a physicochemicalcharacterisationofrinderpestvirus‏ ‎‡A Physico-chemical characterisation of rinderpest virus‏ ‎‡9 1‏
919 ‎‡a nonresponsivenesstoafootandmouthdiseaseviruspeptideovercomebyadditionofforeignhelpertcelldeterminants‏ ‎‡A Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants‏ ‎‡9 1‏
919 ‎‡a newapproachestovaccinationagainstfootandmouthdisease‏ ‎‡A New approaches to vaccination against foot-and-mouth disease‏ ‎‡9 1‏
919 ‎‡a virology‏ ‎‡A Virology‏ ‎‡9 1‏
919 ‎‡a antibodycomplexedfootandmouthdiseasevirusbutnotpolioviruscaninfectnormallyinsusceptiblecellsviathefcreceptor‏ ‎‡A Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor‏ ‎‡9 1‏
919 ‎‡a westnilevirusinbloodstabilitydistributionandsusceptibilitytopen110inactivation‏ ‎‡A West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation‏ ‎‡9 1‏
919 ‎‡a antigenicvariantsinaplaqueisolateoffootandmouthdiseasevirusimplicationsforvaccineproduction‏ ‎‡A Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production‏ ‎‡9 1‏
919 ‎‡a ウイルス học ‏ ‎‡A ウイルス học ‏ ‎‡9 1‏
919 ‎‡a applicationofrnaset11and2dimensionalanalysestotherapididentificationoffootandmouthdiseaseviruses‏ ‎‡A Application of RNase T1 one- and two-dimensional analyses to the rapid identification of foot-and-mouth disease viruses‏ ‎‡9 1‏
919 ‎‡a neutralizingepitopesoftypeofootandmouthdiseasevirus2mapping3conformationalsiteswithsyntheticpeptidereagents‏ ‎‡A Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents‏ ‎‡9 1‏
919 ‎‡a neutralizingepitopesoftypeofootandmouthdiseasevirus1identificationandcharacterizationof3functionallyindependentconformationalsites‏ ‎‡A Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites‏ ‎‡9 1‏
919 ‎‡a neutralizingantibodiestoall7serotypesoffootandmouthdiseaseviruselicitedbysyntheticpeptides‏ ‎‡A Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides‏ ‎‡9 1‏
919 ‎‡a natureoftheinactivatingactionoftrypsinonfootandmouthdiseasevirus‏ ‎‡A Nature of the inactivating action of trypsin on foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a natureoftheantibodyresponsetothefootandmouthdiseasevirusparticleits12sproteinsubunitandtheisolatedimmunizingpolypeptidevp1‏ ‎‡A Nature of the Antibody Response to the Foot-and-Mouth Disease Virus Particle, its 12S Protein Subunit and the Isolated Immunizing Polypeptide VP1‏ ‎‡9 1‏
919 ‎‡a myristylationofpicornaviruscapsidproteinvp4anditsstructuralsignificance‏ ‎‡A Myristylation of picornavirus capsid protein VP4 and its structural significance‏ ‎‡9 1‏
919 ‎‡a morepreciselocationofthepolycytidylicacidtractinfootandmouthdiseasevirusrna‏ ‎‡A More precise location of the polycytidylic acid tract in foot and mouth disease virus RNA‏ ‎‡9 1‏
919 ‎‡a moleculasaspectsoftheantigenicvariationofswinevesiculardiseaseandcoxsackieb5viruses‏ ‎‡A Moleculas aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses.‏ ‎‡9 1‏
919 ‎‡a molecularweightofrhinovirusribonucleicacid‏ ‎‡A Molecular weight of rhinovirus ribonucleic acid‏ ‎‡9 1‏
919 ‎‡a molecularcloningoffootandmouthdiseasevirusgenomeandnucleotidesequencesinthestructuralproteingenes‏ ‎‡A Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes‏ ‎‡9 1‏
919 ‎‡a molecularaspectsoftheantigenicvariationofswinevesiculardiseaseandcoxsackieb5viruses‏ ‎‡A Molecular Aspects of the Antigenic Variation of Swine Vesicular Disease and Coxsackie B5 Viruses‏ ‎‡9 1‏
919 ‎‡a applyingpeptideantigensontobareskininductionofhumoralandcellularimmuneresponsesandpotentialforvaccination‏ ‎‡A Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination.‏ ‎‡9 1‏
919 ‎‡a modelforvesicularstomatitisvirus‏ ‎‡A Model for vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a mimicryofviralepitopeswithretroinversopeptidesofincreasedstability‏ ‎‡A Mimicry of viral epitopes with retro-inverso peptides of increased stability.‏ ‎‡9 1‏
919 ‎‡a locationoftheinitiationsiteforproteinsynthesisonfootandmouthdiseasevirusrnabyinvitrotranslationofdefinedfragmentsoftherna‏ ‎‡A Location of the initiation site for protein synthesis on foot-and-mouth disease virus RNA by in vitro translation of defined fragments of the RNA‏ ‎‡9 1‏
919 ‎‡a lipidandproteinorganizationinvesicularstomatitisandsindbisviruses‏ ‎‡A Lipid and protein organization in vesicular stomatitis and Sindbis viruses‏ ‎‡9 1‏
919 ‎‡a isolationofasolubleandtemplatedependentfootandmouthdiseasevirusrnapolymerase‏ ‎‡A Isolation of a soluble and template-dependent foot-and-mouth disease virus RNA polymerase‏ ‎‡9 1‏
919 ‎‡a bacteriallyexpressedantigenicpeptidefromfootandmouthdiseaseviruscapsidelicitsvariableimmunologicresponsesinanimals‏ ‎‡A Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals‏ ‎‡9 1‏
919 ‎‡a interferingcomponentofvesicularstomatitisvirus‏ ‎‡A Interfering component of vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a infectivevirussubstructurefromvesicularstomatitisvirus‏ ‎‡A Infective virus substructure from vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a infectionofmanbyswinevesiculardiseasevirus‏ ‎‡A Infection of man by swine vesicular disease virus‏ ‎‡9 1‏
919 ‎‡a inducedribonucleicacidsincellsinfectedwithvesicularstomatitisvirus‏ ‎‡A Induced ribonucleic acids in cells infected with vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a inactivationofvirusesbyaziridines‏ ‎‡A Inactivation of viruses by aziridines‏ ‎‡9 1‏
919 ‎‡a baculovirusexpressed2coffootandmouthdiseasevirushasthepotentialfordifferentiatingconvalescentfromvaccinatedanimals‏ ‎‡A Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals‏ ‎‡9 1‏
919 ‎‡a improvedimmunogenicityofapeptideepitopeafterfusiontohepatitisbcoreprotein‏ ‎‡A Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein‏ ‎‡9 1‏
919 ‎‡a immunologicalpropertiesofhepatitisbcoreantigenfusionproteins‏ ‎‡A Immunological properties of hepatitis B core antigen fusion proteins‏ ‎‡9 1‏
919 ‎‡a immunologicalprimingwithsyntheticpeptidesoffootandmouthdiseasevirus‏ ‎‡A Immunological priming with synthetic peptides of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a immunologicalevaluationofthemultipleantigenpeptidemapsystemusingthemajorimmunogenicsiteoffootandmouthdiseasevirus‏ ‎‡A Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a immunologicalevaluationofthemultipleantigenpeptide‏ ‎‡A Immunological evaluation of the multiple antigen peptide‏ ‎‡9 1‏
919 ‎‡a immunogenicandcellattachmentsitesoffmdvfurtherevidencefortheirlocationinasinglecapsidpolypeptide‏ ‎‡A Immunogenic and Cell Attachment Sites of FMDV: Further Evidence for their Location in a Single Capsid Polypeptide‏ ‎‡9 1‏
919 ‎‡a immunizationwithpeptidefunctionalizedcarbonnanotubesenhancesvirusspecificneutralizingantibodyresponses‏ ‎‡A Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses‏ ‎‡9 1‏
919 ‎‡a biochemicalanalysisofavirulentandanavirulentstrainoffootandmouthdiseasevirus‏ ‎‡A Biochemical Analysis of a Virulent and an Avirulent Strain of Foot-and-Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a immuneresponsetouncoupledpeptidesoffootandmouthdiseasevirus‏ ‎‡A Immune response to uncoupled peptides of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a identificationofnativefootandmouthdiseasevirusnonstructuralprotein2casaserologicalindicatortodifferentiateinfectedfromvaccinatedlivestock‏ ‎‡A Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock‏ ‎‡9 1‏
919 ‎‡a hostcellselectionofantigenicvariantsoffootandmouthdiseasevirus‏ ‎‡A Host cell selection of antigenic variants of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a biochemicalaspectsofvariationinfootandmouthdiseasevirus‏ ‎‡A Biochemical Aspects of Variation in Foot-and-Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a cellattachmentsiteonfootandmouthdiseasevirusincludestheaminoacidsequencergd‏ ‎‡A The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD‏ ‎‡9 1‏
919 ‎‡a morphologiccharacteristicsof19santibody‏ ‎‡A The morphologic characteristics of 19S antibody‏ ‎‡9 1‏
919 ‎‡a differentiatingfootandmouthdiseasevirusinfectedfromvaccinatedanimalswithbaculovirusexpressedspecificproteins‏ ‎‡A Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins‏ ‎‡9 1‏
919 ‎‡a assayextractionandstorageofinfectiveribonucleicacidfromfootandmouthdiseasevirus‏ ‎‡A The assay, extraction and storage of infective ribonucleic acid from foot and mouth disease virus‏ ‎‡9 1‏
919 ‎‡a chemicallysynthesizedpeptideselicitneutralizingantibodytobovineenterovirus‏ ‎‡A Chemically Synthesized Peptides Elicit Neutralizing Antibody to Bovine Enterovirus‏ ‎‡9 1‏
919 ‎‡a chemicalbasisofantigenicvariationinfootandmouthdiseasevirus‏ ‎‡A Chemical basis of antigenic variation in foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a antigensofvesicularstomatitisvirus2thepresenceof2lowmolecularweightimmunogensinvirussuspensions‏ ‎‡A The antigens of vesicular stomatitis virus. II. The presence of two low molecular weight immunogens in virus suspensions‏ ‎‡9 1‏
919 ‎‡a characterizationoftheminorpolypeptidesinthefootandmouthdiseaseparticle‏ ‎‡A Characterization of the Minor Polypeptides in the Foot-and-Mouth Disease Particle‏ ‎‡9 1‏
919 ‎‡a delineationofaneutralizingsubregionwithintheimmunodominantepitopeghloopoffootandmouthdiseasevirusvp1whichdoesnotcontainthergdmotif‏ ‎‡A Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.‏ ‎‡9 1‏
919 ‎‡a delineationofaneutralizingsubregionwithintheimmunodominantepitope‏ ‎‡A Delineation of a neutralizing subregion within the immunodominant epitope‏ ‎‡9 1‏
919 ‎‡a enhancedimmunogenicityandcrossreactivityofretroinversopeptidomimeticsofthemajorantigenicsiteoffootandmouthdiseasevirus‏ ‎‡A Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a effectofactinomycin500andguanidineontheformationofaribonucleicacidpolymeraseinducedbyfootandmouthdiseasevirusandonthereplicationofvirusandviralribonucleicacid‏ ‎‡A Effect of actinomycin D and guanidine on the formation of a ribonucleic acid polymerase induced by foot-and mouth-disease virus and on the replication of virus and viral ribonucleic acid‏ ‎‡9 1‏
919 ‎‡a crystallizationandpreliminary10raydiffractionanalysisoffootandmouthdiseasevirus‏ ‎‡A Crystallization and preliminary X-ray diffraction analysis of foot-and-mouth disease virus.‏ ‎‡9 1‏
919 ‎‡a correlationsbetweentheconformationselucidatedby400spectroscopyandtheantigenicpropertiesof4peptidesofthefootandmouthdiseasevirus‏ ‎‡A Correlations between the conformations elucidated by CD spectroscopy and the antigenic properties of four peptides of the foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a controloffootandmouthdiseasebyvaccination‏ ‎‡A Control of foot-and-mouth disease by vaccination‏ ‎‡9 1‏
919 ‎‡a influenceofmitomycin100actinomycin500andultravioletlightonthereplicationofthevirusesoffootandmouthdiseaseandvesicularstomatitis‏ ‎‡A The influence of mitomycin C, actinomycin D and ultraviolet light on the replication of the viruses of foot-and-mouth disease and vesicular stomatitis‏ ‎‡9 1‏
919 ‎‡a effectofvirusinfectiononthestabilityandsynthesisofactinomycinresistantribonucleicacidinbabyhamsterkidneycells‏ ‎‡A Effect of virus infection on the stability and synthesis of actinomycin-resistant ribonucleic acid in baby-hamster kidney cells‏ ‎‡9 1‏
919 ‎‡a effectivesyntheticpeptidevaccineforfootandmouthdiseaseinswine‏ ‎‡A Effective synthetic peptide vaccine for foot-and-mouth disease in swine‏ ‎‡9 1‏
919 ‎‡a efficacyofrabiesvaccinepreparedfromvirusgrowninduckembryo‏ ‎‡A Efficacy of rabies vaccine prepared from virus grown in duck embryo‏ ‎‡9 1‏
919 ‎‡a comparisonoftheantibodieselicitedbytheindividualstructuralpolypeptidesoffootandmouthdiseaseandpolioviruses‏ ‎‡A Comparison of the Antibodies Elicited by the Individual Structural Polypeptides of Foot-and-Mouth Disease and Polio Viruses‏ ‎‡9 1‏
919 ‎‡a encephalomyocarditisvirusantibodiesinserafromapparentlynormalpigs‏ ‎‡A Encephalomyocarditis virus antibodies in sera from apparently normal pigs‏ ‎‡9 1‏
919 ‎‡a comparisonofswinevesiculardiseasevirusandcoxsackieb5virusbyserologicalandrnahybridizationmethods‏ ‎‡A Comparison of Swine Vesicular Disease Virus and Coxsackie B5 Virus by Serological and RNA Hybridization Methods‏ ‎‡9 1‏
919 ‎‡a historyofresearchinfootandmouthdisease‏ ‎‡A The history of research in foot-and-mouth disease‏ ‎‡9 1‏
919 ‎‡a circulardichroismmolecularmodelingandserologyindicatethatthestructuralbasisofantigenicvariationinfootandmouthdiseasevirusisalphahelixformation‏ ‎‡A Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation‏ ‎‡9 1‏
919 ‎‡a locationofthepoly100tractinthernaoffootandmouthdiseasevirus‏ ‎‡A The Location of the Poly(C) Tract in the RNA of Foot-and-Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a classificationofrhabdovirusproteinsaproposal‏ ‎‡A Classification of rhabdovirus proteins: a proposal.‏ ‎‡9 1‏
919 ‎‡a antigensofvesicularstomatitisvirus1separationandimmunogenicityof3complementfixingcomponents‏ ‎‡A The antigens of vesicular stomatitis virus. I. Separation and immunogenicity of three complement-fixing components‏ ‎‡9 1‏
919 ‎‡a antigensofvesicularstomatitisvirus3structureandimmunogenicityofantigensderivedfromthevirionbytreatmentwithtweenandether‏ ‎‡A The antigens of vesicular stomatitis virus. 3. Structure and immunogenicity of antigens derived from the virion by treatment with Tween and ether‏ ‎‡9 1‏
919 ‎‡a syntheticpeptidesmimicsubtypespecificityoffootandmouthdiseasevirus‏ ‎‡A Synthetic peptides mimic subtype specificity of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a syntheticpeptidesaspotentialvaccinesagainstfootandmouthdisease‏ ‎‡A Synthetic peptides as potential vaccines against foot-and-mouth disease‏ ‎‡9 1‏
919 ‎‡a syntheticpeptidebasedvaccineanddiagnosticsystemforeffectivecontroloffmd‏ ‎‡A Synthetic peptide-based vaccine and diagnostic system for effective control of FMD‏ ‎‡9 1‏
919 ‎‡a synthesisofribonucleicacidinbabyhamsterkidneycellsinthepresenceofactinomycin500‏ ‎‡A Synthesis of ribonucleic acid in baby-hamster kidney cells in the presence of actinomycin D.‏ ‎‡9 1‏
919 ‎‡a differentialprecipitationoffootandmouthdiseasevirusproteinsmadeinvivoandinvitrobyhyperimmuneandvirusparticleguineapigantisera‏ ‎‡A Differential precipitation of foot and mouth disease virus proteins made in vivo and in vitro by hyperimmune and virus particle guinea pig antisera‏ ‎‡9 1‏
919 ‎‡a surfacestructureofvesicularstomatitisvirus‏ ‎‡A Surface structure of vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a comparisonofbluetonguetype20withcertainvirusesofthebluetongueandeubenangeeserologicalgroupsoforbiviruses‏ ‎‡A Comparison of Bluetongue Type 20 with Certain Viruses of the Bluetongue and Eubenangee Serological Groups of Orbiviruses‏ ‎‡9 1‏
919 ‎‡a surfacestructureoffootandmouthdiseasevirus‏ ‎‡A Surface structure of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a locationoftheploy100tractinthernaoffootandmouthdiseasevirus‏ ‎‡A The location of the ploy(C) tract in the RNA of foot-and-mouth disease virus.‏ ‎‡9 1‏
919 ‎‡a surfacestructureandrnaproteininteractionsoffootandmouthdiseasevirus‏ ‎‡A Surface structure and RNA-protein interactions of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a structureandimmunogenicityofexperimentalfootandmouthdiseaseandpoliomyelitisvaccines‏ ‎‡A Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines‏ ‎‡9 1‏
919 ‎‡a demonstrationof3specificsitesonthesurfaceoffootandmouthdiseasevirusbyantibodycomplexing‏ ‎‡A Demonstration of three specific sites on the surface of foot-and-mouth disease virus by antibody complexing‏ ‎‡9 1‏
919 ‎‡a characterizationofneutralizingantibodiestobovineenteroviruselicitedbysyntheticpeptides‏ ‎‡A Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides‏ ‎‡9 1‏
919 ‎‡a epitopemappingoffootandmouthdiseaseviruswithneutralizingmonoclonalantibodies‏ ‎‡A Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies‏ ‎‡9 1‏
919 ‎‡a dissectionofvesicularstomatitisvirusintotheinfectiveribonucleoproteinandimmunizingcomponents‏ ‎‡A Dissection of vesicular stomatitis virus into the infective ribonucleoprotein and immunizing components‏ ‎‡9 1‏
919 ‎‡a earlyeventsintheinteractionbetweenfootandmouthdiseasevirusandprimarypigkidneycells‏ ‎‡A Early Events in the Interaction Between Foot-and-Mouth Disease Virus and Primary Pig Kidney Cells‏ ‎‡9 1‏
919 ‎‡a characterizationofanacidresistantmutantoffootandmouthdiseasevirus‏ ‎‡A Characterization of an acid-resistant mutant of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a potentialofretroinversopeptidesassyntheticvaccines‏ ‎‡A The potential of retro-inverso peptides as synthetic vaccines‏ ‎‡9 1‏
919 ‎‡a characterisationofarotavirus20b‏ ‎‡A Characterisation of a rotavirus.20b.‏ ‎‡9 1‏
919 ‎‡a eradicationoffootandmouthdiseaseaparallelproblem‏ ‎‡A The eradication of foot-and-mouth disease: a parallel problem‏ ‎‡9 1‏
919 ‎‡a proteinsofbiologicallyactivesubunitsofvesicularstomatitisvirus‏ ‎‡A The proteins of biologically active sub-units of vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a evidenceforagroupproteininfootandmouthdiseasevirusparticles‏ ‎‡A Evidence for a group protein in foot-and-mouth disease virus particles‏ ‎‡9 1‏
919 ‎‡a characterisationofarotavirus‏ ‎‡A Characterisation of a rotavirus‏ ‎‡9 1‏
919 ‎‡a ribonucleicacidsoftheinfectiveandinterferingcomponentsofvesicularstomatitisvirus‏ ‎‡A The ribonucleic acids of the infective and interfering components of vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a cattleresponsetofootandmouthdiseasevirusnonstructuralproteinsasantigenswithinvaccinesproducedusingdifferentconcentrations‏ ‎‡A Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations‏ ‎‡9 1‏
919 ‎‡a cellattachmentsiteonfootandmouthdiseasevirusincludestheaminoacidsequencergdarginineglycineasparticacid‏ ‎‡A The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).‏ ‎‡9 1‏
919 ‎‡a evidenceforaninternalantigeninfootandmouthdiseasevirus‏ ‎‡A Evidence for an internal antigen in foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a buoyantdensityofpicornavirusesincaesiumsalts‏ ‎‡A Buoyant density of picornaviruses in caesium salts‏ ‎‡9 1‏
919 ‎‡a biochemicalmappingofthefootandmouthdiseasevirusgenome‏ ‎‡A Biochemical Mapping of the Foot-and-Mouth Disease Virus Genome‏ ‎‡9 1‏
919 ‎‡a evidenceforthepersistenceoffootandmouthdiseasevirusinpigs‏ ‎‡A Evidence for the persistence of foot-and-mouth disease virus in pigs‏ ‎‡9 1‏
919 ‎‡a solutionconformationalfeaturesof2highlyhomologousantigenicpeptidesoffootandmouthdiseasevirusserotypeavariantaandusacorrelatewiththeirserologicalproperties‏ ‎‡A The solution conformational features of two highly homologous antigenic peptides of foot-and-mouth disease virus serotype A, variant A and USA, correlate with their serological properties‏ ‎‡9 1‏
919 ‎‡a expressioninyeastofaminoterminalpeptidefusionstohepatitisbcoreantigenandtheirimmunologicalproperties‏ ‎‡A Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties‏ ‎‡9 1‏
919 ‎‡a footandmouthdiseasevirusandpoliovirusparticlescontainproteinsofthereplicationcomplex‏ ‎‡A Foot-and-mouth disease virus and poliovirus particles contain proteins of the replication complex‏ ‎‡9 1‏
919 ‎‡a footandmouthdiseasevirusparticlescontainreplicaseprotein3d‏ ‎‡A Foot-and-mouth disease virus particles contain replicase protein 3D.‏ ‎‡9 1‏
919 ‎‡a furtherevidenceformultipleproteinsinthefootandmouthdiseasevirusparticle‏ ‎‡A Further evidence for multiple proteins in the foot-and-mouth disease virus particle‏ ‎‡9 1‏
919 ‎‡a furtherphysicochemicalcharacterizationofnodamuravirusevidencethatthedividedgenomeoccursinasinglecomponent‏ ‎‡A Further Physicochemical Characterization of Nodamura Virus. Evidence that the Divided Genome Occurs in a Single Component‏ ‎‡9 1‏
919 ‎‡a fusionproteinswithmultiplecopiesofthemajorantigenicdeterminantoffootandmouthdiseasevirusprotectboththenaturalhostandlaboratoryanimals‏ ‎‡A Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals‏ ‎‡9 1‏
919 ‎‡a geneticallyengineeredfootandmouthdiseaseviruseswithpoly100tractsof2nucleotidesarevirulentinmice‏ ‎‡A Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice‏ ‎‡9 1‏
919 ‎‡a glycolipidnatureofthecomplementfixinghostcellantigenofvesicularstomatitisvirus‏ ‎‡A Glycolipid nature of the complement-fixing host cell antigen of vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a heterogeneityofthegenomelinkedproteinoffootandmouthdiseasevirus‏ ‎‡A Heterogeneity of the genome-linked protein of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a structuraldifferencesbetweenfootandmouthdiseaseandpoliomyelitisvirusesinfluencetheirinactivationbyaziridines‏ ‎‡A Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines‏ ‎‡9 1‏
919 ‎‡a structuralcomparisonbetweenretroinversoandparentpeptidesmolecularbasisforthebiologicalactivityofaretroinversoanalogueoftheimmunodominantfragmentofvp1coatproteinfromfootandmouthdiseasevirus‏ ‎‡A Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a structuralandserologicalevidenceforanovelmechanismofantigenicvariationinfootandmouthdiseasevirus‏ ‎‡A Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a stabilisingoralpoliovaccineathighambienttemperatures‏ ‎‡A Stabilising oral poliovaccine at high ambient temperatures‏ ‎‡9 1‏
919 ‎‡a serologicalrelationshipsbetweendifferentstrainsofvesicularstomatisvirus‏ ‎‡A Serological relationships between different strains of vesicular stomatis virus‏ ‎‡9 1‏
919 ‎‡a serologicalprospectsforpeptidevaccinesagainstfootandmouthdiseasevirus‏ ‎‡A Serological prospects for peptide vaccines against foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a serologicalandimmunologicalrelationshipsbetweenthe146sand12sparticlesoffootandmouthdiseasevirus‏ ‎‡A Serological and Immunological Relationships between the 146S and 12S Particles of Foot-and-Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a serologicalandimmunologicalrelationsbetweenthe146sand12sparticlesoffootandmouthdiseasevirus‏ ‎‡A Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.‏ ‎‡9 1‏
919 ‎‡a sequenceidentificationofantigenicvariantsinplaqueisolatesoffootandmouthdiseasevirus‏ ‎‡A Sequence identification of antigenic variants in plaque isolates of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a sequenceandlocationofthepoly100tractinaphthoandcardiovirusrna‏ ‎‡A Sequence and location of the poly C tract in aphtho- and cardiovirus RNA‏ ‎‡9 1‏
919 ‎‡a ribonucleicacidsynthesisinrinderpestvirusinfectedcells‏ ‎‡A Ribonucleic acid synthesis in rinderpest virus infected cells‏ ‎‡9 1‏
919 ‎‡a rhabdoviridaereportoftherhabdovirusstudygroupinternationalcommitteeontaxonomyofviruses‏ ‎‡A Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses‏ ‎‡9 1‏
919 ‎‡a replicationoffootandmouthdiseasevirusribonucleicacid‏ ‎‡A Replication of foot-and-mouth disease virus ribonucleic acid‏ ‎‡9 1‏
919 ‎‡a removalofthegenomelinkedproteinoffootandmouthdiseasevirusbyrabbitreticulocytelysate‏ ‎‡A Removal of the genome-linked protein of foot-and-mouth disease virus by rabbit reticulocyte lysate.‏ ‎‡9 1‏
919 ‎‡a relationshipoftheantigenicstructureoffootandmouthdiseasevirustotheprocessofinfection‏ ‎‡A Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection‏ ‎‡9 1‏
919 ‎‡a relationshipofencephalomyocarditisvirustocricketparalysisvirusofinsects‏ ‎‡A Relationship of Encephalomyocarditis Virus to Cricket Paralysis Virus of Insects‏ ‎‡9 1‏
919 ‎‡a relationshipofavirusfromtellinatenuistoinfectiouspancreaticnecrosisvirus‏ ‎‡A Relationship of a virus from Tellina tenuis to infectious pancreatic necrosis virus‏ ‎‡9 1‏
919 ‎‡a solutionconformationalfeaturesof2highlyhomologousantigenicpeptidesoffootandmouthdiseasevirusserotypeavariantsaandusacorrelatewiththeirserologicalproperties‏ ‎‡A The Solution Conformational Features of Two Highly Homologous Antigenic Peptides of Foot‐and‐mouth Disease Virus Serotype A, Variants A and USA, Correlate with their Serological Properties‏ ‎‡9 1‏
919 ‎‡a solutionstructureoftheimmunodominantandcellreceptorbindingregionsoffootandmouthdiseasevirusserotypeavarianta‏ ‎‡A The Solution Structure of the Immunodominant and Cell Receptor Binding Regions of Foot‐and‐mouth Disease Virus Serotype A, Variant A‏ ‎‡9 1‏
919 ‎‡a structureoffootandmouthdiseasevirusimplicationsforitsphysicalandbiologicalproperties‏ ‎‡A The structure of foot-and-mouth disease virus: implications for its physical and biological properties.‏ ‎‡9 1‏
919 ‎‡a 3dimensionalstructureoffootandmouthdiseasevirusat29aresolution‏ ‎‡A The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution‏ ‎‡9 1‏
919 ‎‡a comparativebiochemicalandserologicalanalysisof5isolatesofasingleserotypeoffootandmouthdiseasevirus‏ ‎‡A Comparative Biochemical and Serological Analysis of Five Isolates of a Single Serotype of Foot-and-Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a reactionsbetweenaninsectpicornavirusandnaturallyoccurringigmantibodiesinseveralmammalianspecies‏ ‎‡A Reactions between an insect picornavirus and naturally occurring IgM antibodies in several mammalian species‏ ‎‡9 1‏
919 ‎‡a trypticpeptideanalysisofthestructuralproteinsofvesicularstomatitisvirus‏ ‎‡A Tryptic Peptide Analysis of the Structural Proteins of Vesicular Stomatitis Virus‏ ‎‡9 1‏
919 ‎‡a useofaportablerealtimereversetranscriptasepolymerasechainreactionassayforrapiddetectionoffootandmouthdiseasevirus‏ ‎‡A Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a useofpeptidesforimmunizationagainstfootandmouthdisease‏ ‎‡A Use of peptides for immunization against foot-and-mouth disease‏ ‎‡9 1‏
919 ‎‡a 3terminalnucleotidesequencesinthegenomernaofpicornaviruses‏ ‎‡A 3′-Terminal nucleotide sequences in the genome RNA of picornaviruses‏ ‎‡9 1‏
919 ‎‡a 400strategyforthestudyofpolypeptidefoldingunfoldingasyntheticfootandmouthdiseasevirusimmunogenicpeptide‏ ‎‡A A CD strategy for the study of polypeptide folding/unfolding. A synthetic foot-and-mouth disease virus immunogenic peptide‏ ‎‡9 1‏
919 ‎‡a comparativechemicalandserologicalstudyofthefullandemptyparticlesoffootandmouthdiseasevirus‏ ‎‡A A Comparative Chemical and Serological Study of the Full and Empty Particles of Foot-and Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a reactionofglutaraldehydewithfoodandmouthdiseasevirus‏ ‎‡A Reaction of glutaraldehyde with food-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a comparativestudyofthesurfaceprojectionsofdifferentstrainsofvesicularstomatitisvirus‏ ‎‡A A Comparative Study of the Surface Projections of Different Strains of Vesicular Stomatitis Virus‏ ‎‡9 1‏
919 ‎‡a footandmouthdiseasesyndromeinpigscausedbyanenterovirus‏ ‎‡A A foot and mouth disease syndrome in pigs caused by an enterovirus‏ ‎‡9 1‏
919 ‎‡a highdensitycomponentinseveralvertebrateenteroviruses‏ ‎‡A A High Density Component in Several Vertebrate Enteroviruses‏ ‎‡9 1‏
919 ‎‡a highproportionofantipeptideantibodiesrecognizefootandmouthdiseasevirusparticles‏ ‎‡A A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles‏ ‎‡9 1‏
919 ‎‡a modelforfootandmouthdiseasevirus‏ ‎‡A A model for foot-and-mouth disease virus‏ ‎‡9 1‏
919 ‎‡a modelforvesicularexanthemavirustheprototypeofthecalicivirusgroup‏ ‎‡A A Model for Vesicular Exanthema Virus, the Prototype of the Calicivirus Group‏ ‎‡9 1‏
919 ‎‡a peptidevaccineadministeredtranscutaneouslytogetherwithcholeratoxinelicitspotentneutralisingantifmdvantibodyresponses‏ ‎‡A A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses‏ ‎‡9 1‏
919 ‎‡a physicochemicalsubgroupingofthemammalianpicornaviruses‏ ‎‡A A physico-chemical sub-grouping of the mammalian picornaviruses‏ ‎‡9 1‏
919 ‎‡a reappraisalofthebiochemicalmapoffootandmouthdiseasevirusrna‏ ‎‡A A Re-appraisal of the Biochemical Map of Foot-and-mouth Disease Virus RNA‏ ‎‡9 1‏
919 ‎‡a rabiesvirusandtheproblemsofrabiesvaccinationinman‏ ‎‡A Rabies virus and the problems of rabies vaccination in man‏ ‎‡9 1‏
919 ‎‡a retroinversopeptidecorrespondingtotheghloopoffootandmouthdiseaseviruselicitshighlevelsoflonglastingprotectiveneutralizingantibodies‏ ‎‡A A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies.‏ ‎‡9 1‏
919 ‎‡a studyoftheheterogeneous37sribonucleicacidinducedbyfootandmouthdiseasevirus‏ ‎‡A A study of the heterogeneous 37S ribonucleic acid induced by foot-and-mouth-disease virus‏ ‎‡9 1‏
919 ‎‡a studyofthelevelofnucleotidesequenceconservationbetweenthernasof2serotypesoffootandmouthdiseasevirus‏ ‎‡A A Study of the Level of Nucleotide Sequence Conservation between the RNAs of Two Serotypes of Foot-and-Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a studyofthelevelofnucleotidesequenceconservationbetweenthernasof2typesserotypesoffootandmouthdiseasevirus‏ ‎‡A A study of the level of nucleotide sequence conservation between the RNAs of two types serotypes of foot-and-mouth disease virus.‏ ‎‡9 1‏
919 ‎‡a syntheticpeptidecontainingtheconsensussequenceoftheghloopregionoffootandmouthdiseasevirustypeovp1andapromiscuousthelperepitopeinducespeptidespecificantibodiesbutfailstoprotectcattleagainstviralchallenge‏ ‎‡A A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge‏ ‎‡9 1‏
919 ‎‡a syntheticpeptidewhichelicitsneutralizingantibodyagainsthumanrhinovirustype2‏ ‎‡A A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2‏ ‎‡9 1‏
919 ‎‡a universalvirusinactivantfordecontaminatingbloodandbiopharmaceuticalproducts‏ ‎‡A A universal virus inactivant for decontaminating blood and biopharmaceutical products‏ ‎‡9 1‏
919 ‎‡a variationinfootandmouthdiseasevirusisolatesinkenyaanexaminationoffieldisolatesbyt1oligonucleotidefingerprinting‏ ‎‡A Variation in foot-and-mouth disease virus isolates in Kenya: an examination of field isolates by T1 oligonucleotide fingerprinting‏ ‎‡9 1‏
919 ‎‡a rabiesvirusandlaboratoryregulations‏ ‎‡A Rabies virus and laboratory regulations‏ ‎‡9 1‏
919 ‎‡a absenceofpoly‏ ‎‡A Absence of poly‏ ‎‡9 1‏
919 ‎‡a absenceofpolyafromtheinfectivernaofnodamuravirus‏ ‎‡A Absence of Poly (A) from the Infective RNA of Nodamura Virus‏ ‎‡9 1‏
919 ‎‡a absenceofprotein2cfromclarifiedfootandmouthdiseasevirusvaccinesprovidesthebasisfordistinguishingconvalescentfromvaccinatedanimals‏ ‎‡A Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals‏ ‎‡9 1‏
919 ‎‡a assessmentbycompetitionhybridizationofthesequencehomologybetweenthernasofthe7serotypesoffmdv‏ ‎‡A An Assessment by Competition Hybridization of the Sequence Homology between the RNAs of the Seven Serotypes of FMDV‏ ‎‡9 1‏
919 ‎‡a rabiesvaccinesforanimalsandman‏ ‎‡A Rabies vaccines for animals and man‏ ‎‡9 1‏
919 ‎‡a questionsconcerningthepotencyofrabiesvaccine‏ ‎‡A Questions concerning the potency of rabies vaccine‏ ‎‡9 1‏
919 ‎‡a inactivatedbabyhamsterkidneycellrabiesvaccineforuseindogsandcattle‏ ‎‡A An Inactivated Baby Hamster Kidney Cell Rabies Vaccine for Use in Dogs and Cattle‏ ‎‡9 1‏
919 ‎‡a interferingcomponentofrabiesviruswhichcontainsrna‏ ‎‡A An interfering component of rabies virus which contains RNA.‏ ‎‡9 1‏
919 ‎‡a analysisofthesecondarystructureofthepoly‏ ‎‡A Analysis of the secondary structure of the poly‏ ‎‡9 1‏
919 ‎‡a analysisofthesecondarystructureofthepoly100tractinfootandmouthdiseasevirusrnas‏ ‎‡A Analysis of the secondary structure of the poly(C) tract in foot-and-mouth disease virus RNAs‏ ‎‡9 1‏
919 ‎‡a qualitativeandquantitativedifferencesintheimmuneresponsetofootandmouthdiseasevirusantigensandsyntheticpeptides‏ ‎‡A Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides‏ ‎‡9 1‏
919 ‎‡a purificationandphysicochemicalcharacteristicsofafricanswinefevervirus‏ ‎‡A Purification and physicochemical characteristics of African swine fever virus‏ ‎‡9 1‏
919 ‎‡a purificationandidentificationofthernadependentrnapolymeraseoffootandmouthdiseasevirus‏ ‎‡A Purification and Identification of the RNA-dependent RNA Polymerase of Foot-and-Mouth Disease Virus‏ ‎‡9 1‏
919 ‎‡a proteinsinducedbyinfectionwithcaliciviruses‏ ‎‡A Proteins Induced by Infection with Caliciviruses‏ ‎‡9 1‏
919 ‎‡a proteincovalentlylinkedtofootandmouthdiseasevirusrna‏ ‎‡A Protein covalently linked to foot-and-mouth disease virus RNA‏ ‎‡9 1‏
919 ‎‡a protectionofswinefromfootandmouthdiseasewith1doseofanall500retropeptide‏ ‎‡A Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide.‏ ‎‡9 1‏
919 ‎‡a protectionagainstfootandmouthdiseasebyimmunizationwithachemicallysynthesizedpeptidepredictedfromtheviralnucleotidesequence‏ ‎‡A Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence‏ ‎‡9 1‏
919 ‎‡a proposalforauniformnomenclaturefordefectiveinterferingvirusesofvesicularstomatitisvirus‏ ‎‡A Proposal for a uniform nomenclature for defective interfering viruses of vesicular stomatitis virus‏ ‎‡9 1‏
919 ‎‡a progressandperspectivesinthedevelopmentofafootandmouthdiseasevaccinebyrecombinantdnatechnology‏ ‎‡A Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.‏ ‎‡9 1‏
919 ‎‡a presentationandimmunogenicityofviralepitopesonthesurfaceofhybridhepatitisbviruscoreparticlesproducedinbacteria‏ ‎‡A Presentation and Immunogenicity of Viral Epitopes on the Surface of Hybrid Hepatitis B Virus Core Particles Produced in Bacteria‏ ‎‡9 1‏
919 ‎‡a presenceofacovalentlylinkedproteinoncalicivirusrna‏ ‎‡A Presence of a Covalently Linked Protein on Calicivirus RNA‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
947 ‎‡a GB‏ ‎‡9 1‏
947 ‎‡a United Kingdom of Great Britain and Ireland‏ ‎‡9 1‏
996 ‎‡2 LC|n 95081181‏
996 ‎‡2 ISNI|0000000498384304‏
996 ‎‡2 ISNI|0000000067252836‏
996 ‎‡2 BNF|12257193‏
996 ‎‡2 SIMACOB|59082339‏
996 ‎‡2 LC|n 88095405‏
996 ‎‡2 LC|n 2014066621‏
996 ‎‡2 BIBSYS|90360197‏
996 ‎‡2 CAOONL|ncf10102877‏
996 ‎‡2 ISNI|0000000033629295‏
996 ‎‡2 NII|DA07100615‏
996 ‎‡2 BIBSYS|90073213‏
996 ‎‡2 BIBSYS|90287403‏
996 ‎‡2 BIBSYS|90261610‏
996 ‎‡2 J9U|987007407790505171‏
996 ‎‡2 ISNI|0000000433526906‏
996 ‎‡2 LC|no2017073275‏
996 ‎‡2 BIBSYS|90206124‏
996 ‎‡2 RERO|A005504715‏
996 ‎‡2 SUDOC|079970869‏
996 ‎‡2 BNF|16920253‏
996 ‎‡2 LC|n 94066960‏
996 ‎‡2 ISNI|0000000000935034‏
996 ‎‡2 CAOONL|ncf10102127‏
996 ‎‡2 NUKAT|n 2010167121‏
996 ‎‡2 NII|DA09292630‏
996 ‎‡2 NSK|000721727‏
996 ‎‡2 LC|no2015077611‏
996 ‎‡2 PTBNP|1047566‏
996 ‎‡2 NTA|411847279‏
996 ‎‡2 BIBSYS|6002733‏
996 ‎‡2 LC|n 81120808‏
996 ‎‡2 ISNI|0000000116847597‏
996 ‎‡2 LC|no2021120200‏
996 ‎‡2 SUDOC|07565413X‏
996 ‎‡2 NUKAT|n 98005169‏
996 ‎‡2 LC|nb2009020178‏
996 ‎‡2 SUDOC|18089126X‏
996 ‎‡2 N6I|vtls000083205‏
996 ‎‡2 SELIBR|197367‏
996 ‎‡2 ISNI|0000000394081982‏
996 ‎‡2 NUKAT|n 96001859‏
996 ‎‡2 NII|DA07796655‏
996 ‎‡2 LC|no2009179516‏
996 ‎‡2 BIBSYS|90379776‏
996 ‎‡2 BNC|981058512055206706‏
996 ‎‡2 NII|DA03484694‏
996 ‎‡2 NII|DA19542370‏
996 ‎‡2 NII|DA07095264‏
996 ‎‡2 NII|DA00917423‏
996 ‎‡2 NTA|32115584X‏
996 ‎‡2 RERO|A003048098‏
996 ‎‡2 BIBSYS|90311815‏
996 ‎‡2 PLWABN|9810644691805606‏
996 ‎‡2 NTA|376145226‏
996 ‎‡2 LC|n 90670301‏
996 ‎‡2 ISNI|0000000397257701‏
996 ‎‡2 BNF|12339053‏
996 ‎‡2 LC|n 80162074‏
996 ‎‡2 SUDOC|159727820‏
996 ‎‡2 ISNI|0000000440044737‏
996 ‎‡2 SUDOC|251526291‏
996 ‎‡2 CAOONL|ncf11213416‏
996 ‎‡2 SUDOC|280100728‏
996 ‎‡2 LC|no2008004398‏
996 ‎‡2 ISNI|0000000029157109‏
996 ‎‡2 J9U|987007431734505171‏
996 ‎‡2 NII|DA01309762‏
996 ‎‡2 J9U|987007450444405171‏
996 ‎‡2 LC|no2017032725‏
996 ‎‡2 LC|nb2005018302‏
996 ‎‡2 NII|DA09580511‏
996 ‎‡2 NSK|000650881‏
996 ‎‡2 LC|no2004039363‏
996 ‎‡2 NUKAT|n 97088208‏
996 ‎‡2 RERO|A025990085‏
996 ‎‡2 NTA|070201331‏
996 ‎‡2 J9U|987007277001905171‏
996 ‎‡2 NUKAT|n 2004044704‏
996 ‎‡2 BIBSYS|5016715‏
996 ‎‡2 SUDOC|026657775‏
996 ‎‡2 SUDOC|031337473‏
996 ‎‡2 J9U|987007385983805171‏
996 ‎‡2 NII|DA05463979‏
996 ‎‡2 RERO|A011093721‏
996 ‎‡2 ISNI|0000000112978450‏
996 ‎‡2 ISNI|0000000067866520‏
996 ‎‡2 LC|n 87827229‏
996 ‎‡2 LC|no2013140738‏
996 ‎‡2 LC|n 85321717‏
996 ‎‡2 LC|no2015042497‏
996 ‎‡2 BNF|11886459‏
996 ‎‡2 J9U|987007360295605171‏
996 ‎‡2 LC|n 95110786‏
996 ‎‡2 SUDOC|158498933‏
996 ‎‡2 BIBSYS|90508457‏
996 ‎‡2 ISNI|0000000030108179‏
996 ‎‡2 N6I|vtls000082243‏
996 ‎‡2 BNF|14012588‏
996 ‎‡2 NUKAT|n 2017008306‏
996 ‎‡2 ISNI|0000000067815889‏
996 ‎‡2 BIBSYS|97013509‏
996 ‎‡2 SUDOC|182082490‏
996 ‎‡2 DNB|1019962453‏
996 ‎‡2 ISNI|0000000440041894‏
996 ‎‡2 LC|no 96031195‏
996 ‎‡2 NII|DA05421334‏
996 ‎‡2 RERO|A008614722‏
996 ‎‡2 LC|nb2002041927‏
996 ‎‡2 BIBSYS|90166439‏
996 ‎‡2 CAOONL|ncf11268025‏
996 ‎‡2 CAOONL|ncf10071958‏
996 ‎‡2 NII|DA05191405‏
996 ‎‡2 PTBNP|452414‏
996 ‎‡2 BIBSYS|90311772‏
996 ‎‡2 RERO|A023747154‏
996 ‎‡2 LC|n 85368750‏
996 ‎‡2 NII|DA05867876‏
996 ‎‡2 LC|nb 97079207‏
996 ‎‡2 SUDOC|170528022‏
996 ‎‡2 ISNI|0000000046723635‏
996 ‎‡2 LC|n 83057494‏
996 ‎‡2 J9U|987007366367105171‏
996 ‎‡2 J9U|987007314100005171‏
996 ‎‡2 BIBSYS|90329189‏
996 ‎‡2 BIBSYS|90085276‏
996 ‎‡2 LC|n 88600491‏
996 ‎‡2 DNB|1089816197‏
996 ‎‡2 LC|no2008169535‏
996 ‎‡2 LC|n 2022043739‏
996 ‎‡2 SUDOC|137384084‏
996 ‎‡2 NTA|191041181‏
996 ‎‡2 NTA|100903118‏
996 ‎‡2 LC|no2001067682‏
996 ‎‡2 SUDOC|270813721‏
996 ‎‡2 NTA|315862238‏
996 ‎‡2 LC|n 88651847‏
996 ‎‡2 BIBSYS|90150625‏
996 ‎‡2 LC|n 85360439‏
996 ‎‡2 SUDOC|176591761‏
996 ‎‡2 LC|no2003110468‏
996 ‎‡2 BIBSYS|8029416‏
996 ‎‡2 CAOONL|ncf11749965‏
996 ‎‡2 NII|DA04943946‏
996 ‎‡2 ISNI|0000000035307839‏
996 ‎‡2 LC|n 87154032‏
996 ‎‡2 ISNI|0000000021492981‏
996 ‎‡2 RERO|A005509318‏
996 ‎‡2 W2Z|1707990463859‏
996 ‎‡2 NTA|189843608‏
996 ‎‡2 RERO|A018747235‏
996 ‎‡2 DNB|171392132‏
996 ‎‡2 ISNI|0000000077387814‏
996 ‎‡2 BIBSYS|90113558‏
996 ‎‡2 BIBSYS|90574184‏
996 ‎‡2 ISNI|0000000394233624‏
996 ‎‡2 LC|no2024011073‏
996 ‎‡2 NTA|220287538‏
996 ‎‡2 RERO|A011968730‏
996 ‎‡2 LC|no2008180040‏
996 ‎‡2 ISNI|000000003066065X‏
996 ‎‡2 NUKAT|n 2007124388‏
996 ‎‡2 RERO|A026417148‏
996 ‎‡2 NTA|217653707‏
996 ‎‡2 SUDOC|270779159‏
996 ‎‡2 ISNI|000000003025618X‏
996 ‎‡2 NUKAT|n 2010083056‏
996 ‎‡2 LC|n 87123782‏
996 ‎‡2 NLA|000035022597‏
996 ‎‡2 LC|n 83125133‏
996 ‎‡2 ISNI|0000000050365498‏
996 ‎‡2 NII|DA04678211‏
996 ‎‡2 BIBSYS|90230349‏
996 ‎‡2 RERO|A003048108‏
996 ‎‡2 RERO|A024362584‏
996 ‎‡2 RERO|A003048100‏
996 ‎‡2 BNF|17034556‏
996 ‎‡2 RERO|A003048106‏
996 ‎‡2 NUKAT|n 2005001539‏
996 ‎‡2 RERO|A003047805‏
996 ‎‡2 NII|DA03452202‏
996 ‎‡2 LC|nb2003098335‏
996 ‎‡2 SUDOC|085834904‏
996 ‎‡2 SUDOC|08102021X‏
996 ‎‡2 BIBSYS|1707990463859‏
996 ‎‡2 KRNLK|KAC200803919‏
996 ‎‡2 RERO|A006077661‏
996 ‎‡2 LC|n 80015044‏
996 ‎‡2 BNF|12483655‏
996 ‎‡2 BLBNB|000621879‏
996 ‎‡2 LC|no2015003819‏
996 ‎‡2 SUDOC|233977481‏
996 ‎‡2 NTA|258322152‏
996 ‎‡2 CAOONL|ncf10403830‏
996 ‎‡2 LC|nb2013020241‏
996 ‎‡2 BNF|12053178‏
996 ‎‡2 BIBSYS|1055356‏
996 ‎‡2 ISNI|0000000091346146‏
996 ‎‡2 LC|no2021068965‏
996 ‎‡2 LC|n 91103063‏
996 ‎‡2 LC|n 88282594‏
996 ‎‡2 BAV|495_142257‏
996 ‎‡2 DNB|173363334‏
996 ‎‡2 ISNI|0000000371328962‏
996 ‎‡2 ISNI|0000000051031393‏
996 ‎‡2 CAOONL|ncf11335983‏
996 ‎‡2 LC|n 82019099‏
996 ‎‡2 RERO|A006372222‏
996 ‎‡2 J9U|987007317389805171‏
996 ‎‡2 ISNI|0000000063927488‏
996 ‎‡2 LC|n 2014190847‏
996 ‎‡2 NUKAT|n 2013079095‏
996 ‎‡2 ISNI|0000000008910210‏
996 ‎‡2 LC|n 80121571‏
996 ‎‡2 CAOONL|ncf10026706‏
996 ‎‡2 NUKAT|n 2019017764‏
996 ‎‡2 NUKAT|n 2021006916‏
996 ‎‡2 J9U|987007339841005171‏
996 ‎‡2 ISNI|0000000025665077‏
996 ‎‡2 ISNI|0000000033976203‏
996 ‎‡2 NUKAT|n 2020010532‏
996 ‎‡2 LC|no2010126557‏
996 ‎‡2 SUDOC|227528166‏
996 ‎‡2 NTA|072845546‏
996 ‎‡2 CAOONL|ncf11066166‏
996 ‎‡2 ISNI|0000000048972184‏
996 ‎‡2 NII|DA09207493‏
996 ‎‡2 SUDOC|085995177‏
996 ‎‡2 ISNI|0000000039852113‏
996 ‎‡2 PLWABN|9810695193305606‏
996 ‎‡2 NII|DA13899823‏
996 ‎‡2 LC|n 50035026‏
996 ‎‡2 NSK|000650674‏
996 ‎‡2 ISNI|000000002495802X‏
996 ‎‡2 BIBSYS|90953651‏
996 ‎‡2 LC|n 92062762‏
996 ‎‡2 RERO|A003722795‏
996 ‎‡2 NTA|071781277‏
996 ‎‡2 ISNI|0000000110050448‏
996 ‎‡2 LC|nb2009012071‏
996 ‎‡2 NUKAT|n 2013055163‏
996 ‎‡2 SUDOC|254287670‏
996 ‎‡2 ISNI|0000000048268103‏
996 ‎‡2 J9U|987009748375505171‏
996 ‎‡2 LC|n 88612353‏
996 ‎‡2 SUDOC|264207459‏
996 ‎‡2 ISNI|0000000425072924‏
996 ‎‡2 LC|no2007132106‏
996 ‎‡2 SUDOC|076406415‏
996 ‎‡2 J9U|987007298321005171‏
997 ‎‡a 1925 2004 lived 0131 0220‏ ‎‡9 1‏
998 ‎‡a Brown, Fred,‏ ‎‡2 NTA|072009314‏ ‎‡3 suggested‏ ‎‡3 partial date, partial title‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred‏ ‎‡2 NII|DA01820134‏ ‎‡3 exact title: (1.00, 'virology', 'virology')‏
998 ‎‡a Brown, Fred,‏ ‎‡2 NKC|nlk20050163294‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred,‏ ‎‡2 LNB|LNC10-000126490‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred,‏ ‎‡2 CAOONL|ncf11189156‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred‏ ‎‡2 NUKAT|n 2006126157‏ ‎‡3 single date‏ ‎‡3 exact title: (1.00, 'virology', 'virology')‏
998 ‎‡a Brown, Fred,‏ ‎‡2 J9U|987007442565705171‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown‏ ‎‡b Fred‏ ‎‡2 BNF|12280479‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred‏ ‎‡2 BIBSYS|90230349‏ ‎‡3 viafid‏
998 ‎‡a Brown, Fred‏ ‎‡2 ISNI|0000000114475742‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a BROWN, F.‏ ‎‡2 ISNI|0000000114475742‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Fred Brown‏ ‎‡c biologiste, en poste: Plum Island disease center, Greenport, N. Y.‏ ‎‡2 ISNI|0000000114475742‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred‏ ‎‡2 ISNI|0000000114475742‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, F.‏ ‎‡2 ISNI|0000000114475742‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred‏ ‎‡2 ISNI|0000000114475742‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred,‏ ‎‡2 SUDOC|031625770‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred‏ ‎‡2 DNB|171991923‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏
998 ‎‡a Brown, Fred,‏ ‎‡2 LC|n 84219996‏ ‎‡3 suggested‏ ‎‡3 double date‏ ‎‡3 single date‏